Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep220 | Cardiovascular Endocrinology and Lipid Metabolism | ECE2016

Comparison of serum thyroid stimulating hormone and anti-thyroid peroxidase antibody levels in euthyroid subjects with and without metabolic syndrome

Serin Sibel Ocak , Kocoglu Hakan , Okuturlar Yildiz , Dogan Hakan , Gedikbasi Asuman , Utku Irem Kirac , Demir Esra , Yesil Ezgi Ersoy , Koc Guven , Eyupgiller Tulay , Ucak Sema , Harmankaya Ozlem

Objective: The present study aimed to evaluate thyroid stimulating hormone (TSH) levels and anti-thyroid peroxidase antibodies (anti-TPOab) in euthyroid subjects with metabolic syndrome (MetS) and to compare them with healthy subjects without MetS.Design: Study included 173 subjects consisted of 96 subjects with MetS and 77 healthy controls. Gender, age, body mass index (BMI), waist circumfrence (WC), and detailed medical history of all participants were...

ea0056p377 | Diabetes (to include epidemiology, pathophysiology) | ECE2018

TWEAK levels in patients with prediabetes and diabetes mellitus

Okuturlar Yildiz , Kocoglu Hakan , Serin Sibel Ocak , Ercan Tarik , Hursitoglu Mehmet , Mert Meral , Ozdemir Bahar , Erismis Betul , Gedikbasi Asuman , Harmankaya Ozlem

Introduction: Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) belongs to TNF family and is released from inflammatory cells. It has been reported that TWEAK has several biological actions ranging from cell proliferation to stimulation of apoptosis. In in vitro studies, it was reported that TWEAK has alleviating effect on insulin resistance in hepatocytes. TWEAK decreases insulin resistance induced by TNF-a through activation of phosphatase 2A pathway in a...